Shanghai Shyndec Pharmaceutical Co Ltd (600420) — Financial Flexibility Index
Shanghai Shyndec Pharmaceutical Co Ltd (600420) has a Financial Flexibility Index of 0.15x as of September 2025. Free cash flow of CN¥553.14 Million (operating CF CN¥486.04 Million minus capex CN¥67.11 Million) represents 0% of total liabilities (CN¥3.63 Billion). Check 600420 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Shanghai Shyndec Pharmaceutical Co Ltd Financial Flexibility Index (2004–2024)
Historical Financial Flexibility Index trend for Shanghai Shyndec Pharmaceutical Co Ltd across 21 annual periods. For the full cash flow conversion analysis, see 600420 cash flow metrics.
Annual Financial Flexibility Index for Shanghai Shyndec Pharmaceutical Co Ltd (2004–2024)
Year-by-year free cash flow to debt coverage for Shanghai Shyndec Pharmaceutical Co Ltd. Explore Shanghai Shyndec Pharmaceutical Co Ltd (600420) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.53x | CN¥2.48 Billion | CN¥2.26 Billion | CN¥4.63 Billion | ▲ +28.9% |
| 2023 | 0.41x | CN¥2.08 Billion | CN¥1.72 Billion | CN¥5.01 Billion | ▼ -2.0% |
| 2022 | 0.42x | CN¥3.16 Billion | CN¥2.86 Billion | CN¥7.48 Billion | ▲ +67.2% |
| 2021 | 0.25x | CN¥2.20 Billion | CN¥1.68 Billion | CN¥8.70 Billion | ▲ +10.1% |
| 2020 | 0.23x | CN¥1.94 Billion | CN¥1.56 Billion | CN¥8.43 Billion | ▲ +15.8% |
| 2019 | 0.20x | CN¥1.67 Billion | CN¥1.27 Billion | CN¥8.44 Billion | ▼ -23.1% |
| 2018 | 0.26x | CN¥2.07 Billion | CN¥1.67 Billion | CN¥8.02 Billion | ▼ -21.9% |
| 2017 | 0.33x | CN¥2.48 Billion | CN¥2.31 Billion | CN¥7.52 Billion | ▲ +146.9% |
| 2016 | 0.13x | CN¥1.08 Billion | CN¥838.58 Million | CN¥8.08 Billion | ▼ -26.8% |
| 2015 | 0.18x | CN¥461.17 Million | CN¥226.65 Million | CN¥2.53 Billion | ▼ -36.0% |
| 2014 | 0.29x | CN¥689.05 Million | CN¥258.51 Million | CN¥2.42 Billion | ▼ -27.9% |
| 2013 | 0.40x | CN¥720.12 Million | CN¥207.50 Million | CN¥1.82 Billion | ▼ -15.6% |
| 2012 | 0.47x | CN¥598.94 Million | CN¥193.41 Million | CN¥1.28 Billion | ▼ -3.5% |
| 2011 | 0.49x | CN¥264.52 Million | CN¥136.12 Million | CN¥544.70 Million | ▼ -46.6% |
| 2010 | 0.91x | CN¥271.12 Million | CN¥115.11 Million | CN¥298.05 Million | ▲ +51.4% |
| 2009 | 0.60x | CN¥128.73 Million | CN¥97.43 Million | CN¥214.24 Million | ▲ +37.1% |
| 2008 | 0.44x | CN¥71.60 Million | CN¥58.04 Million | CN¥163.41 Million | ▼ -55.1% |
| 2007 | 0.98x | CN¥116.76 Million | CN¥82.31 Million | CN¥119.57 Million | ▼ -38.0% |
| 2006 | 1.57x | CN¥135.59 Million | CN¥73.60 Million | CN¥86.15 Million | ▲ +29.6% |
| 2005 | 1.21x | CN¥129.55 Million | CN¥57.90 Million | CN¥106.67 Million | ▲ +175.1% |
| 2004 | 0.44x | CN¥32.81 Million | CN¥17.02 Million | CN¥74.32 Million | — |